Insider · CIK 0001235471
Elaine J Heron
Files at VXRT (Vaxart, Inc.), PVLA (PALVELLA THERAPEUTICS, INC.). First filing Nov 21, 2025, latest Nov 21, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
VXRT: Vaxart, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | VXRT Vaxart, Inc. | POpen-market purchase Common Stock | +23,217 | $0.39 | $9,124 | 79,783 | Nov 21, 2025 |
| Nov 17, 2025 | VXRT Vaxart, Inc. | POpen-market purchase Common Stock | +16,783 | $0.41 | $6,797 | 96,566 | Nov 21, 2025 |
| Jun 13, 2025 | VXRT Vaxart, Inc. | AGrant or award Common Stock | +16,000 | $0.00 | $0 | 56,566 | Jun 16, 2025 |
| Jun 13, 2025 | VXRT Vaxart, Inc. | AGrant or award Stock Option (right to buy)derivative | +95,400 | $0.00 | $0 | 95,400 | Jun 16, 2025 |
| Jun 10, 2025 | PVLA PALVELLA THERAPEUTICS, INC. | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +12,350 | $0.00 | $0 | 12,350 | Jun 11, 2025 |
| Dec 13, 2024 | PVLA PALVELLA THERAPEUTICS, INC. | AGrant or award Stock Option (right to buy)derivative | +24,700 | $0.00 | $0 | 24,700 | Dec 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.